Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients. | Molecules | 2022 | 36144737 | PubTator, text mining | PubMed |
| Role of Epitranscriptomic and Epigenetic Modifications during the Lytic and Latent Phases of Herpesvirus Infections. | Microorganisms | 2022 | 36144356 | PubTator, text mining | PubMed |
| Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas. | Int J Mol Sci | 2022 | 36142875 | PubTator, text mining | PubMed |
| TIAM2 Contributes to Osimertinib Resistance, Cell Motility, and Tumor-Associated Macrophage M2-like Polarization in Lung Adenocarcinoma. | Int J Mol Sci | 2022 | 36142328 | PubTator, text mining | PubMed |
| NFkB Pathway and Hodgkin Lymphoma. | Biomedicines | 2022 | 36140254 | PubTator, text mining | PubMed |
| Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations. | Biomedicines | 2022 | 36140243 | PubTator, text mining | PubMed |
| The Features of Checkpoint Receptor-Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition. | Biomedicines | 2022 | 36140182 | PubTator, text mining | PubMed |
| A Human Stem Cell-Derived Neurosensory-Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation. | Biomedicines | 2022 | 36140168 | PubTator, text mining | PubMed |
| Review Article: Immune Landscape and Immunotherapy Options in Cervical Carcinoma. | Cancers (Basel) | 2022 | 36139618 | PubTator, text mining | PubMed |
| Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246. | Br J Cancer | 2022 | 36138076 | PubTator, text mining | PubMed |
| SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics. | Medicine (Baltimore) | 2022 | 36123895 | PubTator, text mining | PubMed |
| CAR-T cell potency: from structural elements to vector backbone components. | Biomark Res | 2022 | 36123710 | PubTator, text mining | PubMed |
| Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response. | Signal Transduct Target Ther | 2022 | 36123348 | PubTator, text mining | PubMed |
| Determination of a prediction model for therapeutic response and prognosis based on chemokine signaling-related genes in stage I-III lung squamous cell carcinoma. | Front Genet | 2022 | 36118890 | PubTator, text mining | PubMed |
| Multi-omic Characterization of Pancreatic Ductal Adenocarcinoma Relates CXCR4 mRNA Expression Levels to Potential Clinical Targets. | Clin Cancer Res | 2022 | 36112544 | PubTator, text mining | PubMed |
| Prognostic model based on m6A-associated lncRNAs in esophageal cancer. | Front Endocrinol (Lausanne) | 2022 | 36111294 | PubTator, text mining | PubMed |
| CD160 Promotes NK Cell Functions by Upregulating Glucose Metabolism and Negatively Correlates With HIV Disease Progression. | Front Immunol | 2022 | 36110864 | PubTator, text mining | PubMed |
| Predicting prognosis and immune responses in hepatocellular carcinoma based on N7-methylguanosine-related long noncoding RNAs. | Front Genet | 2022 | 36110218 | PubTator, text mining | PubMed |
| Human immunomodulatory ligand B7-1 mediates synaptic remodeling via the p75 neurotrophin receptor. | J Clin Invest | 2022 | 36107635 | PubTator, text mining | PubMed |
| Subtype Classification and Prognosis Signature Construction of Osteosarcoma Based on Cellular Senescence-Related Genes. | J Oncol | 2022 | 36106335 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=51